"Azasteroids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Steroidal compounds in which one or more carbon atoms in the steroid ring system have been substituted with nitrogen atoms.
Below are MeSH descriptors whose meaning is more general than "Azasteroids".
Below are MeSH descriptors whose meaning is more specific than "Azasteroids".
This graph shows the total number of publications written about "Azasteroids" by people in Harvard Catalyst Profiles by year, and whether "Azasteroids" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 2 | 1 | 3 |
| 2009 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 4 | 0 | 4 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
Below are the most recent publications written about "Azasteroids" by people in Profiles.
-
Solifenacin or mirabegron could improve persistent overactive bladder symptoms after dutasteride treatment in patients with benign prostatic hyperplasia. Urology. 2015 May; 85(5):1151-1155.
-
Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2014 Dec; 17(4):325-31.
-
Dutasteride in men receiving testosterone therapy: a randomised, double-blind study. Andrologia. 2015 Mar; 47(2):148-52.
-
Targeted androgen pathway suppression in localized prostate cancer: a pilot study. J Clin Oncol. 2014 Jan 20; 32(3):229-37.
-
Goodbye androgen hypothesis, hello saturation model. Eur Urol. 2012 Nov; 62(5):765-7.
-
Effect of testosterone supplementation with and without a dual 5a-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial. JAMA. 2012 Mar 07; 307(9):931-9.
-
Dutasteride for the treatment of prostate-related conditions. Expert Opin Drug Saf. 2012 Mar; 11(2):325-30.
-
Ask the doctor. I take Avodart for my enlarged prostate. But I heard that Avodart increases prostate cancer risk. Is that true? Should I quit taking Avodart? Harv Health Lett. 2012 Jan; 37(3):8.
-
Samarium diiodide induced ketyl-(het)arene cyclisations towards novel N-heterocycles. Chem Soc Rev. 2011 May; 40(5):2199-210.
-
Battling prostate cancer with 5-alpha-reductase inhibitors: a pyrrhic victory? J Gen Intern Med. 2011 Jul; 26(7):798-801.